Cargando…

Subtle immunodeficiencies in nodular–bronchiectatic Mycobacterium avium complex lung disease

Patients with nodular–bronchiectatic MAC lung disease have dysregulated adaptive immunity with defective IL-17 and IFN-γ production, and IL-10 overproduction. This suggests a role for adjunctive immunomodulatory treatments. https://bit.ly/33AALwx

Detalles Bibliográficos
Autores principales:	Bruno, Mariolina, Zweijpfenning, Sanne M.H., Verhoeven, Jeske, Boeree, Martin J., Netea, Mihai G., van de Veerdonk, Frank L., van Ingen, Jakko, Hoefsloot, Wouter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Respiratory Society 2020
Materias:	Original Research Letters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7569207/ https://www.ncbi.nlm.nih.gov/pubmed/33123562 http://dx.doi.org/10.1183/23120541.00548-2020

Ejemplares similares

Immune defects in patients with pulmonary Mycobacterium abscessus disease without cystic fibrosis
por: Schuurbiers, Milou M.F., et al.
Publicado: (2020)

Treatment of severe Mycobacterium avium complex pulmonary disease with adjunctive amikacin and clofazimine versus standard regimen alone: a retrospective study
por: Zweijpfenning, Sanne M.H., et al.
Publicado: (2021)

Mycobacterium Growth Indicator Tube Time-To-Positivity Can Serve As an Early Biomarker of Treatment Response in Mycobacterium avium Complex Pulmonary Disease
por: Danho, Rabi, et al.
Publicado: (2022)

Consolidations in Nodular Bronchiectatic Mycobacterium Avium Complex Lung Disease: Mycobacterium Avium Complex or Other Infection?
por: Im, Soo Ah, et al.
Publicado: (2010)

A Case of Follicular Bronchiolitis as the Histological Counterpart to Nodular Opacities in Bronchiectatic Mycobacterium avium Complex Disease
por: Wakamatsu, Kentaro, et al.
Publicado: (2012)

Outcome of shorter treatment duration in non-cavitary nodular bronchiectatic Mycobacterium avium complex lung disease
por: Park, Yea Eun, et al.
Publicado: (2020)

The role of rifampicin within the treatment of Mycobacterium avium pulmonary disease
por: Schildkraut, Jodie A., et al.
Publicado: (2023)

Retrospective study of the predictors of mortality and radiographic deterioration in 782 patients with nodular/bronchiectatic Mycobacterium avium complex lung disease
por: Gochi, Mina, et al.
Publicado: (2015)

Natural course of the nodular bronchiectatic form of Mycobacterium Avium complex lung disease: Long-term radiologic change without treatment
por: Park, Tae Yun, et al.
Publicado: (2017)

The epidemiology of nontuberculous mycobacterial pulmonary disease in the Netherlands
por: Schildkraut, Jodie Anne, et al.
Publicado: (2021)

Mycobacterium xenopi Clinical Relevance and Determinants, the Netherlands
por: van Ingen, Jakko, et al.
Publicado: (2008)

Comparison of Clinical and Radiographic Characteristics between Nodular Bronchiectatic Form of Nontuberculous Mycobacterial Lung Disease and Diffuse Panbronchiolitis
por: Park, Hye Yun, et al.
Publicado: (2009)

High-dose rifampicin in tuberculosis: Experiences from a Dutch tuberculosis centre
por: Seijger, Charlotte, et al.
Publicado: (2019)

Multicentre, open label, randomised controlled trial comparing intermittent versus daily treatment for non-cavitary nodular/bronchiectatic Mycobacterium avium complex lung disease with rifampicin, ethambutol and clarithromycin (iREC): study protocol
por: Nakagawa, Taku, et al.
Publicado: (2019)

Survival of bronchiectatic patients with respiratory failure in ICU
por: Alzeer, Abdulaziz H, et al.
Publicado: (2007)

Empyema, Basal Lung Disease, and Bronchiectatic Cavities
por: James, Alex.
Publicado: (1892)

Empyema, Basal Lung Disease, and Bronchiectatic Cavities
por: James, Alexander
Publicado: (1892)

Normalization of Elevated CA 19-9 Level after Treatment in a Patient with the Nodular Bronchiectatic Form of Mycobacterium abscessus Lung Disease
por: Chang, Boksoon, et al.
Publicado: (2013)

Otomastoiditis Caused by Mycobacterium abscessus, the Netherlands
por: van Ingen, Jakko, et al.
Publicado: (2010)

Safety and Outcomes of Amikacin Liposome Inhalation Suspension for Mycobacterium abscessus Pulmonary Disease: A NTM-NET study
por: Henriette Zweijpfenning, Sanne Maria, et al.
Publicado: (2022)

Epidemiology of Mycobacterium bovis Disease in Humans, the Netherlands, 1993–2007
por: Majoor, Christof J., et al.
Publicado: (2011)

Time-to-positivity of Mycobacterium avium complex in broth culture associates with culture conversion
por: Mingora, Christina M., et al.
Publicado: (2022)

The tough process of unmasking the slow-growing mycobacterium: case report of Mycobacterium microti infection
por: van de Weg, Cornelia A. M., et al.
Publicado: (2019)

Characterization of Mycobacterium orygis as M. tuberculosis Complex Subspecies
por: van Ingen, Jakko, et al.
Publicado: (2012)

High mortality in patients with Mycobacterium avium complex lung disease: a systematic review
por: Diel, Roland, et al.
Publicado: (2018)

Management of Drug Toxicity in Mycobacterium avium Complex Pulmonary Disease: An Expert Panel Survey
por: van Ingen, Jakko, et al.
Publicado: (2020)

An Exaggerated Monocyte-Derived Cytokine Response to Candida Hyphae in Patients With Recurrent Vulvovaginal Candidiasis
por: Rosati, Diletta, et al.
Publicado: (2020)

Conjunction of a Fungus Ball and a Pulmonary Tumourlet in a Bronchiectatic Cavity
por: Yazgan, Serkan, et al.
Publicado: (2018)

Is there a role for tedizolid in the treatment of non-tuberculous mycobacterial disease?
por: Ruth, Mike Marvin, et al.
Publicado: (2020)

Nontuberculous Mycobacteria in Respiratory Tract Infections, Eastern Asia
por: Simons, Sami, et al.
Publicado: (2011)

The Antipsychotic Thioridazine Shows Promising Therapeutic Activity in a Mouse Model of Multidrug-Resistant Tuberculosis
por: van Soolingen, Dick, et al.
Publicado: (2010)

Invasive candidiasis presenting bronchiectatic cavity as chest radiological findings: A case report
por: Ijiri, Atsuhiro, et al.
Publicado: (2023)

Genetic susceptibility to Candida infections
por: Smeekens, Sanne P, et al.
Publicado: (2013)

MGIT Enriched Shotgun Metagenomics for Routine Identification of Nontuberculous Mycobacteria: a Route to Personalized Health Care
por: Schildkraut, Jodie A., et al.
Publicado: (2023)

T-cell Subsets and Antifungal Host Defenses
por: van de Veerdonk, Frank L., et al.
Publicado: (2010)

New Insights in the Immunobiology of IL-1 Family Members
por: van de Veerdonk, Frank L., et al.
Publicado: (2013)

Blocking IL-1 to prevent respiratory failure in COVID-19
por: van de Veerdonk, Frank L., et al.
Publicado: (2020)

Rare variants increase the risk of severe COVID-19
por: van de Veerdonk, Frank L, et al.
Publicado: (2021)

Inhaled tigecycline is effective against Mycobacterium abscessus in vitro and in vivo
por: Pearce, Camron, et al.
Publicado: (2020)

Data of common and species-specific transcriptional host responses to pathogenic fungi
por: Bruno, Mariolina, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_vsnf5hmjnkrkcolkthsbkb7v0h